You Searched For: MARKET+SOURCE+PART+PROCESS


45,911  results were found

SearchResultCount:"45911"

Sort Results

List View Easy View

Rate These Search Results

Catalog Number: (MSPP1824512)
Supplier: MARKET SOURCE PART PROCESS
Description: TD-NMR Glass tubes with a lenght of 180 mm.
UOM: 1 * 100 items

Market Source Item This is a MarketSource item. Additional charges may apply

Catalog Number: (MSPPDIUR-100)
Supplier: MARKET SOURCE PART PROCESS
Description: For quantitative determination of urea and evaluation of drug effects on urea metabolism.
UOM: 1 * 1 KIT

Market Source Item This is a MarketSource item. Additional charges may apply

All-day power. Every day durability

Work quickly with the compact, powerful M510 and M611 Label Printers, delivering high-volume, high-quality labels via Bluetooth or Wi-Fi

Learn more

Meet the M510 & M611 Label printers

Catalog Number: (MSPPA/3446/50)
Supplier: MARKET SOURCE PART PROCESS
Description: Ammonium acetate
UOM: 1 * 250 g

Market Source Item This is a MarketSource item. Additional charges may apply

Catalog Number: (MSPPCOR61.5-0.75)
Supplier: MARKET SOURCE PART PROCESS
Description: Manufactured from 316L pharmaceutical grade stainless steel, Pharma Hygiene Products’ concentric reducers provide the perfect solution for connecting existing Tri-Clamp connections to newer or changing ones.
UOM: 1 * 1 items

Market Source Item This is a MarketSource item. Additional charges may apply

Catalog Number: (MSPPB21732012)
Supplier: MARKET SOURCE PART PROCESS
Description: Manufactured from 316L pharmaceutical grade stainless steel, Pharma Hygiene Products’ Tri-Clamp Blank Caps are designed to blank off Ferrule Ends, when used with Tri-Clamp gaskets and clamps.
UOM: 1 * 1 items

Market Source Item This is a MarketSource item. Additional charges may apply

Catalog Number: (MSPPA40040-25.0)
Supplier: MARKET SOURCE PART PROCESS
Description: Inhibitor of bacterial cell wall synthesis resulting in lysis or deformation of the bacterium.
UOM: 1 * 25 g

Market Source Item This is a MarketSource item. Additional charges may apply

Catalog Number: (MSPPG8830A)
Supplier: MARKET SOURCE PART PROCESS
Description: The AriaMx real-time PCR system is a fully integrated quantitative PCR amplification, detection and data analysis system.
UOM: 1 * 1 items

Market Source Item This is a MarketSource item. Additional charges may apply

Catalog Number: (116-0000)
Supplier: MARKET SOURCE PART PROCESS
Description: A universal oil and chemical binder safely absorbs all liquids without restriction and within a few minutes. Shows no dangerous reaction, not even with strongly reacting and oxidising substances such as nitric acid, oleum, hydrofluoric acid, bromine, sulphuric acid or hydrogen peroxide. Acts as an emission blocker by creating a steam barrier that protects both personnel and the environment. Once in contact with acid spillages, the binder changes from light green to yellow, where as with alkaline substances the green becomes darker.
UOM: 1 * 5 kg

Market Source Item This is a MarketSource item. Additional charges may apply

Catalog Number: (MSPPG1)
Supplier: MARKET SOURCE PART PROCESS
Description: Autoclave bags, medium, for hazardous waste disposal.
UOM: 1 * 1.500 items

Market Source Item This is a MarketSource item. Additional charges may apply

Catalog Number: (MSPPNIC210712-1CS)
Supplier: MARKET SOURCE PART PROCESS
Description: SJ-27F oil is used in all lubricated JUN-Air compressors which helps prevent corrosion, assist in cooling and extends valve life. It has to be changed every two years. Used on M3, M4, M6, M12, M18, M24 and M36 models.
UOM: 1 * 12 items


Supplier: HTDIALYSIS
Description: HTD reusable equilibrium dialysis device combines industry-leading accuracy and precision with an automation compatible design for a cost efficient, scalable solution.

Catalog Number: (MSPPRH1010.0500S)
Supplier: MARKET SOURCE PART PROCESS
Description: Dichloromethane for HPLC
UOM: 1 * 500 mL

Market Source Item This is a MarketSource item. Additional charges may apply

Catalog Number: (MSPPRH1011GSK-1)
Supplier: MARKET SOURCE PART PROCESS
Description: Tetrahydrofuran
UOM: 1 * 1 L

Market Source Item This is a MarketSource item. Additional charges may apply

Catalog Number: (BOSSBS-4107R-HRP)
Supplier: Bioss
Description: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface.
UOM: 1 * 100 µl


Catalog Number: (BOSSBS-4107R-A750)
Supplier: Bioss
Description: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilises MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. .
UOM: 1 * 100 µl


Catalog Number: (BOSSBS-4107R-A488)
Supplier: Bioss
Description: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface.
UOM: 1 * 100 µl


Inquire for Price
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the call is still displayed and you need assistance, please call us on 0800 22 33 44.
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the call is still displayed and you need assistance, please call us on 0800 22 33 44
Additional Documentation may be needed to purchase this item. A VWR representative will contact you if needed.
Additional Documentation may be needed to purchase this item. A VWR representative will contact you if needed.
This product has been blocked by your organisation. Please contact your purchasing department for more information.
The original product is no longer available. The replacement shown is available.
Product(s) marked with this symbol are discontinued - sold till end of stock. Alternatives may be available by searching with the VWR Catalogue Number listed above. If you need further assistance, please call VWR Customer Service on 0800 22 33 44.
1 - 16 of 45,911
no targeter for Bottom